• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION INVIVE; IMPLANTABLE DEVICE Back to Search Results
Model Number V173
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problems No Code Available (3191); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/08/2020
Event Type  Injury  
Manufacturer Narrative
(b)(4).Information indicates this device is currently in the possession of the explanting hospital.This investigation will be updated should further information be provided.
 
Event Description
It was reported that a remote monitoring transmission was received by the healthcare provider (hcp) which indicated that this cardiac resynchronization therapy pacemaker (crt-p) device had reverted to safety mode with limited critical therapy still available.Boston scientific technical services (ts) discussed with the hcp what safety mode means, indicated that the device needs to be replaced and suggested talking with the patient about any exposure to radiation or other things that may have caused the device to revert to safety mode.The hcp noted that the patient is pace therapy dependent and indicated that they will review this issue with the physician.The device was subsequently explanted and replaced three (3) days later.As part of this replacement procedure, the device was interrogated, and the safety mode codes that were observed all indicate a device memory issue.No additional adverse patient effects were reported.
 
Manufacturer Narrative
Patient code 3191 captures the reportable event of surgery.Information indicates this device is currently in the possession of the explanting hospital.This investigation will be updated should further information be provided.The device was returned to boston scientific and device analysis was completed.Upon receipt at our post market quality assurance laboratory, this device was thoroughly inspected and analyzed.A review of device memory confirmed it was operating in safety mode and brady therapy remained available while implanted.The memory review also found that faults occurred indicating there were memory errors.However, the specific memory errors observed will not cause the device to reset and operate in safety mode.The device was then exposed to simulated heart load conditions, and the pacing, and sensing functions were tested.Normal operation was observed.The results of the device analysis confirm the clinical observation, but the root cause of the failure could not be confirmed.
 
Event Description
It was reported that a remote monitoring transmission was received by the healthcare provider (hcp) which indicated that this cardiac resynchronization therapy pacemaker (crt-p) device had reverted to safety mode with limited critical therapy still available.Boston scientific technical services (ts) discussed with the hcp what safety mode means, indicated that the device needs to be replaced and suggested talking with the patient about any exposure to radiation or other things that may have caused the device to revert to safety mode.The hcp noted that the patient is pace therapy dependent and indicated that they will review this issue with the physician.The device was subsequently explanted and replaced three (3) days later.As part of this replacement procedure, the device was interrogated, and the safety mode codes that were observed all indicate a device memory issue.No additional adverse patient effects were reported.The device was returned to boston scientific and device analysis was completed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INVIVE
Type of Device
IMPLANTABLE DEVICE
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
MDR Report Key10638263
MDR Text Key210159223
Report Number2124215-2020-19386
Device Sequence Number1
Product Code NKE
UDI-Device Identifier00802526536632
UDI-Public00802526536632
Combination Product (y/n)N
PMA/PMN Number
P030005/S079
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 04/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/06/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date05/27/2015
Device Model NumberV173
Device Catalogue NumberV173
Device Lot Number103666
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/21/2020
Date Manufacturer Received03/05/2021
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age82 YR
-
-